Latuda Dosing Guidelines
Schizophrenia
For adults with schizophrenia, start Latuda at 40 mg once daily with food (at least 350 calories), with an effective dose range of 40-160 mg/day and maximum dose of 160 mg/day; no initial titration is required. 1
- Adolescents (13-17 years): Start at 40 mg once daily, effective range 40-80 mg/day, maximum 80 mg/day 1
- Administration with food is mandatory—it increases absorption approximately 2-fold (AUC) and 3-fold (Cmax) 1
Bipolar I Depression
For adults with bipolar I depression, start Latuda at 20 mg once daily (whether as monotherapy or adjunctive to lithium/valproate), with an effective range of 20-120 mg/day and maximum dose of 120 mg/day; notably, higher doses (80-120 mg/day) did not provide additional efficacy compared to lower doses (20-60 mg/day) in monotherapy studies. 1
The optimal therapeutic dose based on recent meta-analysis is 40-60 mg daily (specifically 50 mg showed SMD -0.60 for depression improvement), balancing efficacy with side effect profile 2. This dose range demonstrates:
- Superior depression reduction (SMD -0.60)
- Improved anxiety (SMD -0.32)
- Better clinical global impression (SMD -0.67)
- Reduced disability (SMD -0.38)
Pediatric patients (10-17 years): Start at 20 mg once daily, may increase after one week based on response, effective range 20-80 mg/day, maximum 80 mg/day. In clinical studies, 67% of patients received 20-40 mg/day at study end 1
Hepatic Impairment Dosing
For moderate hepatic impairment (Child-Pugh B, score 7-9), start at 20 mg/day with a maximum dose of 80 mg/day. 1
For severe hepatic impairment (Child-Pugh C, score 10-15), start at 20 mg/day with a maximum dose of 40 mg/day. 1
These dose reductions are necessary because patients with moderate to severe hepatic impairment have higher lurasidone exposure, increasing the risk of adverse reactions 1
Renal Impairment Dosing
For moderate renal impairment (CrCl 30 to <50 mL/min) or severe renal impairment (CrCl <30 mL/min), start at 20 mg/day with a maximum dose of 80 mg/day. 1
Drug Interaction Adjustments
- Contraindicated: Do not use with strong CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir, voriconazole) 1
- Moderate CYP3A4 inhibitors: Dose adjustment required (specific guidance in full prescribing information) 1
Critical Administration Points
- Always administer with food (minimum 350 calories) to ensure adequate absorption 1
- No initial dose titration required for standard adult dosing in schizophrenia or bipolar depression 1
- For bipolar depression specifically, the 20-60 mg/day range appears optimal based on efficacy data, as the 80-120 mg/day range showed no additional benefit 1, 2
Special Population Considerations
- Elderly: No specific dose adjustment required based on age alone, though 20 mg/day showed similar concentrations to younger patients 1
- Asian patients: Expert consensus supports 20 mg/day starting dose with titration up to 120 mg/day for adults, 20-80 mg/day for elderly 3
- No adjustment needed for sex, race, or smoking status 1